Opioid-related genetic polymorphisms do not influence postoperative opioid requirement: A prospective observational study |
journalArticle |
2018 |
Aubrun, F.; Zahr, N.; Langeron, O.; Boccheciampe, N.; Cozic, N.; Belin, L.; Hulot, J. S.; Khiami, F.; Riou, B. |
Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer |
journalArticle |
2016 |
Michiels, S.; Pugliano, L.; Marguet, S.; Grun, D.; Barinoff, J.; Cameron, D.; Cobleigh, M.; Di Leo, A.; Johnston, S.; Gasparini, G.; Kaufman, B.; Marty, M.; Nekljudova, V.; Paluch-Shimon, S.; Penault-Llorca, F.; Slamon, D.; Vogel, C.; von Minckwitz, G.; Buyse, M.; Piccart, M. |
Reply to V.P. Retel et al, D. Gauchan et al, and C. Rahilly-Tierney et al |
journalArticle |
2015 |
Bonastre, J.; Marguet, S.; Lueza, B.; Michiels, S.; Delaloge, S.; Saghatchian, M. |
Phase I trial evaluating the antiviral agent Cidofovir in combination with chemoradiation in cervical cancer patients |
journalArticle |
2016 |
Deutsch, E.; Haie-Meder, C.; Bayar, M. A.; Mondini, M.; Laporte, M.; Mazeron, R.; Adam, J.; Varga, A.; Vassal, G.; Magne, N.; Chargari, C.; Lanoy, E.; Pautier, P.; Levy, A.; Soria, J. C. |
Impact of experience in breast cancer surgery on survival: the role of quality of care in a registry-based cohort. |
journalArticle |
2018 |
Taban F, Elia N, Rapiti E, Rageth C, Fioretta G, Benhamou S, Than Lam G, David-Montefiore E, Bouchardy C |
Long-term evaluation of urinary, sexual, and quality of life outcomes after brachytherapy for penile carcinoma |
journalArticle |
2018 |
Gambachidze, D.; Lebacle, C.; Maroun, P.; Escande, A.; Bossi, A.; Blanchard, P.; Deutsch, E.; Haie-Meder, C.; Chargari, C. |
MRI-guided brachytherapy in locally advanced cervical cancer: Small bowel [Formula: see text] and [Formula: see text] are not predictive of late morbidity |
journalArticle |
2016 |
Petit, C.; Dumas, I.; Chargari, C.; Martinetti, F.; Maroun, P.; Doyeux, K.; Tailleur, A.; Haie-Meder, C.; Mazeron, R. |
Impact of prophylactic central neck dissection on oncologic outcomes of papillary thyroid carcinoma: a review |
journalArticle |
2015 |
Mamelle, E.; Borget, I.; Leboulleux, S.; Mirghani, H.; Suárez, C.; Pellitteri, P. K.; Shaha, A. R.; Hamoir, M.; Robbins, K. T.; Khafif, A.; Rodrigo, J. P.; Silver, C. E.; Rinaldo, A.; Ferlito, A.; Hartl, D. M. |
Outcome According to Elective Pelvic Radiation Therapy in Patients With High-Risk Localized Prostate Cancer: A Secondary Analysis of the GETUG 12 Phase 3 Randomized Trial |
journalArticle |
2016 |
Blanchard, P.; Faivre, L.; Lesaunier, F.; Salem, N.; Mesgouez-Nebout, N.; Deniau-Alexandre, E.; Rolland, F.; Ferrero, J. M.; Houede, N.; Mourey, L.; Theodore, C.; Krakowski, I.; Berdah, J. F.; Baciuchka, M.; Laguerre, B.; Davin, J. L.; Habibian, M.; Culine, S.; Laplanche, A.; Fizazi, K. |
Single-use flexible bronchoscopes compared with reusable bronchoscopes: Positive organizational impact but a costly solution |
journalArticle |
2018 |
Châteauvieux, C.; Farah, L.; Guérot, E.; Wermert, D.; Pineau, J.; Prognon, P.; Borget, I.; Martelli, N. |
Integrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratification |
journalArticle |
2017 |
Andreiuolo, F.; Le Teuff, G.; Bayar, M. A.; Kilday, J. P.; Pietsch, T.; von Bueren, A. O.; Witt, H.; Korshunov, A.; Modena, P.; Pfister, S. M.; Pagès, M.; Castel, D.; Giangaspero, F.; Chimelli, L.; Varlet, P.; Rutkowski, S.; Frappaz, D.; Massimino, M.; Grundy, R.; Grill, J. |
Inter-observer variability in target delineation increases during adaptive treatment of head-and-neck and lung cancer |
journalArticle |
2019 |
Apolle, R.; Appold, S.; Bijl, H. P.; Blanchard, P.; Bussink, J.; Faivre-Finn, C.; Khalifa, J.; Laprie, A.; Lievens, Y.; Madani, I.; Ruffier, A.; de Ruysscher, D.; van Elmpt, W.; Troost, E. G. C. |
Percutaneous lung thermal ablation of non-surgical clinical N0 non-small cell lung cancer: results of eight years' experience in 87 patients from two centers |
journalArticle |
2015 |
Palussiere, J.; Lagarde, P.; Auperin, A.; Deschamps, F.; Chomy, F.; de Baere, T. |
Multivariate joint frailty model for the analysis of nonlinear tumor kinetics and dynamic predictions of death |
journalArticle |
2018 |
Krol, A.; Tournigand, C.; Michiels, S.; Rondeau, V. |
Trends in tobacco-attributable mortality in France |
journalArticle |
2015 |
Ribassin-Majed, L.; Hill, C. |
[Individual patient data meta-analyses of randomized trials for the treatment of non-metastatic head and neck squamous cell carcinomas: Principles, results and perspectives] |
journalArticle |
2015 |
Blanchard, P.; Bourhis, J.; Lacas, B.; Le Teuff, G.; Michiels, S.; Pignon, J. P. |
Clinical use of magnetic resonance imaging across the prostate brachytherapy workflow |
journalArticle |
2017 |
Blanchard, P.; Menard, C.; Frank, S. J. |
Can we cure patients with abdominal Desmoplastic Small Round Cell Tumor? Results of a retrospective multicentric study on 100 patients |
journalArticle |
2019 |
Honore, C.; Delhorme, J. B.; Nassif, E.; Faron, M.; Ferron, G.; Bompas, E.; Glehen, O.; Italiano, A.; Bertucci, F.; Orbach, D.; Pocard, M.; Quenet, F.; Blay, J. Y.; Carrere, S.; Chevreau, C.; Mir, O.; Le Cesne, A. |
Treatment strategies in early-stage oropharyngeal squamous cell carcinoma: a French national survey |
journalArticle |
2016 |
Gorphe, P.; Blanchard, P.; Moriniere, S.; Fakhry, N. |
[Hypofractionad radiotherapy for elderly with head and neck cancer] |
journalArticle |
2018 |
Ortholan, C.; Auperin, A.; Mertens, C.; Le Caer, H.; Guigay, J. |
Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection |
journalArticle |
2015 |
Tsao, M. S.; Marguet, S.; Le Teuff, G.; Lantuejoul, S.; Shepherd, F. A.; Seymour, L.; Kratzke, R.; Graziano, S. L.; Popper, H. H.; Rosell, R.; Douillard, J. Y.; Le-Chevalier, T.; Pignon, J. P.; Soria, J. C.; Brambilla, E. M. |
Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial |
journalArticle |
2016 |
Piperno-Neumann, S.; Le Deley, M. C.; Redini, F.; Pacquement, H.; Marec-Berard, P.; Petit, P.; Brisse, H.; Lervat, C.; Gentet, J. C.; Entz-Werle, N.; Italiano, A.; Corradini, N.; Bompas, E.; Penel, N.; Tabone, M. D.; Gomez-Brouchet, A.; Guinebretiere, J. M.; Mascard, E.; Gouin, F.; Chevance, A.; Bonnet, N.; Blay, J. Y.; Brugieres, L.; Sarcoma Group of, Unicancer; French Society of Pediatric, Oncology; French Sarcoma, Group |
Predisposing factors of liver necrosis after transcatheter arterial chemoembolization in liver metastases from neuroendocrine tumor |
journalArticle |
2015 |
Joskin, J.; de Baere, T.; Auperin, A.; Tselikas, L.; Guiu, B.; Farouil, G.; Boige, V.; Malka, D.; Leboulleux, S.; Ducreux, M.; Baudin, E.; Deschamps, F. |
[Oral cavity cancers among young people: Clinical results and prognostic analysis] |
journalArticle |
2016 |
Blanchard, P.; El Khoury, C.; Temam, S.; Casiraghi, O.; Mirghani, H.; Levy, A.; Gorphe, P.; Even, C.; De Felice, F.; Nguyen, F.; Janot, F.; Tao, Y. |
Mortality analyses in the updated French cohort of uranium miners (1946-2007) |
journalArticle |
2015 |
Rage, E.; Caer-Lorho, S.; Drubay, D.; Ancelet, S.; Laroche, P.; Laurier, D. |
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial |
journalArticle |
2015 |
Le Tourneau, C.; Delord, J. P.; Goncalves, A.; Gavoille, C.; Dubot, C.; Isambert, N.; Campone, M.; Tredan, O.; Massiani, M. A.; Mauborgne, C.; Armanet, S.; Servant, N.; Bieche, I.; Bernard, V.; Gentien, D.; Jezequel, P.; Attignon, V.; Boyault, S.; Vincent-Salomon, A.; Servois, V.; Sablin, M. P.; Kamal, M.; Paoletti, X.; investigators, Shiva |
Estimating causal effects of time-dependent exposures on a binary endpoint in a high-dimensional setting |
journalArticle |
2018 |
Asvatourian, V.; Coutzac, C.; Chaput, N.; Robert, C.; Michiels, S.; Lanoy, E. |
Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents |
journalArticle |
2016 |
Merlevede, J.; Droin, N.; Qin, T.; Meldi, K.; Yoshida, K.; Morabito, M.; Chautard, E.; Auboeuf, D.; Fenaux, P.; Braun, T.; Itzykson, R.; de Botton, S.; Quesnel, B.; Commes, T.; Jourdan, E.; Vainchenker, W.; Bernard, O.; Pata-Merci, N.; Solier, S.; Gayevskiy, V.; Dinger, M. E.; Cowley, M. J.; Selimoglu-Buet, D.; Meyer, V.; Artiguenave, F.; Deleuze, J. F.; Preudhomme, C.; Stratton, M. R.; Alexandrov, L. B.; Padron, E.; Ogawa, S.; Koscielny, S.; Figueroa, M.; Solary, E. |
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis |
journalArticle |
2015 |
Blanchard, P.; Lee, A.; Marguet, S.; Leclercq, J.; Ng, W. T.; Ma, J.; Chan, A. T.; Huang, P. Y.; Benhamou, E.; Zhu, G.; Chua, D. T.; Chen, Y.; Mai, H. Q.; Kwong, D. L.; Cheah, S. L.; Moon, J.; Tung, Y.; Chi, K. H.; Fountzilas, G.; Zhang, L.; Hui, E. P.; Lu, T. X.; Bourhis, J.; Pignon, J. P.; Group, Mac-Npc Collaborative |
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group |
journalArticle |
2016 |
Denkert, C.; Wienert, S.; Poterie, A.; Loibl, S.; Budczies, J.; Badve, S.; Bago-Horvath, Z.; Bane, A.; Bedri, S.; Brock, J.; Chmielik, E.; Christgen, M.; Colpaert, C.; Demaria, S.; Van den Eynden, G.; Floris, G.; Fox, S. B.; Gao, D.; Ingold Heppner, B.; Kim, S. R.; Kos, Z.; Kreipe, H. H.; Lakhani, S. R.; Penault-Llorca, F.; Pruneri, G.; Radosevic-Robin, N.; Rimm, D. L.; Schnitt, S. J.; Sinn, B. V.; Sinn, P.; Sirtaine, N.; O'Toole, S. A.; Viale, G.; Van de Vijver, K.; de Wind, R.; von Minckwitz, G.; Klauschen, F.; Untch, M.; Fasching, P. A.; Reimer, T.; Willard-Gallo, K.; Michiels, S.; Loi, S.; Salgado, R. |
Long-Term Outcome After Surgery for a Localized Retroperitoneal Soft Tissue Sarcoma in Elderly Patients: Results from a Retrospective, Single-Center Study |
journalArticle |
2018 |
Sourrouille, I.; Macovei, R.; Faron, M.; Le Pechoux, C.; Mir, O.; Adam, J.; Dumont, S.; Terrier, P.; Le Cesne, A.; Honore, C. |
A randomized trial of induction docetaxel-cisplatin-5FU followed by concomitant cisplatin-RT versus concomitant cisplatin-RT in nasopharyngeal carcinoma (GORTEC 2006-02) |
journalArticle |
2018 |
Frikha, M.; Auperin, A.; Tao, Y.; Elloumi, F.; Toumi, N.; Blanchard, P.; Lang, P.; Sun, S.; Racadot, S.; Thariat, J.; Alfonsi, M.; Tuchais, C.; Cornely, A.; Moussa, A.; Guigay, J.; Daoud, J.; Bourhis, J.; Gortec |
Impact of primary para-aortic lymphadenectomy on distant failure in locally advanced cervical cancer patients treated in the era of image-guided adaptive brachytherapy |
journalArticle |
2016 |
Chargari, C.; Mazeron, R.; Dunant, A.; Gouy, S.; Petit, C.; Maroun, P.; Uzan, C.; Annede, P.; Bentivegna, E.; Balleyguier, C.; Genestie, C.; Pautier, P.; Leary, A.; Lhomme, C.; Deutsch, E.; Morice, P.; Haie-Meder, C. |
Quelles exigences pour qu'un biomarqueur puisse être un critère de substitution acceptable ? |
journalArticle |
2016 |
Paoletti, X.; Rotolo, F.; Michiels, S. |
Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:21-30 |
journalArticle |
2016 |
Blanchard, P.; Briganti, A.; Bossi, A. |
Overall survival of children and adolescents with mature B cell non-Hodgkin lymphoma who had refractory or relapsed disease during or after treatment with FAB/LMB 96: A report from the FAB/LMB 96 study group |
journalArticle |
2018 |
Cairo, M.; Auperin, A.; Perkins, S. L.; Pinkerton, R.; Harrison, L.; Goldman, S.; Patte, C. |
The protein phosphatase 2A regulatory subunit PR70 is a gonosomal melanoma tumor suppressor gene |
journalArticle |
2016 |
van Kempen, L. C.; Redpath, M.; Elchebly, M.; Klein, K. O.; Papadakis, A. I.; Wilmott, J. S.; Scolyer, R. A.; Edqvist, P. H.; Ponten, F.; Schadendorf, D.; van Rijk, A. F.; Michiels, S.; Dumay, A.; Helbling-Leclerc, A.; Dessen, P.; Wouters, J.; Stass, M.; Greenwood, C. M.; Ghanem, G. E.; van den Oord, J.; Feunteun, J.; Spatz, A. |
Continuation versus discontinuation of first-line chemotherapy in patients with metastatic squamous cell oesophageal cancer: A randomised phase II trial (E-DIS) |
journalArticle |
2019 |
Adenis, A.; Bennouna, J.; Etienne, P. L.; Bogart, E.; Francois, E.; Galais, M. P.; Ben Abdelghani, M.; Michel, P.; Metges, J. P.; Dahan, L.; Conroy, T.; Ghiringhelli, F.; Drouillard, A.; El Hajbi, F.; Samalin, E.; Hiret, S.; Delaine-Clisant, S.; Mariette, C.; Penel, N.; Piessen, G.; Le Deley, M. C. |
Added Value of Whole-Exome and Transcriptome Sequencing for Clinical Molecular Screenings of Advanced Cancer Patients With Solid Tumors |
journalArticle |
2018 |
Koeppel, F.; Bobard, A.; Lefebvre, C.; Pedrero, M.; Deloger, M.; Boursin, Y.; Richon, C.; Chen-Min-Tao, R.; Robert, G.; Meurice, G.; Rouleau, E.; Michiels, S.; Massard, C.; Scoazec, J. Y.; Solary, E.; Soria, J. C.; André, F.; Lacroix, L. |
Optimizing Local Control in High-Grade Uterine Sarcoma: Adjuvant Vaginal Vault Brachytherapy as Part of a Multimodal Treatment |
journalArticle |
2017 |
Annede, P.; Gouy, S.; Mazeron, R.; Bentivegna, E.; Maroun, P.; Petit, C.; Dumas, I.; Leary, A.; Genestie, C.; Lhomme, C.; Deutsch, E.; Morice, P.; Pautier, P.; Haie-Meder, C.; Chargari, C. |